3. Droll A, Dougherty ST, Chiu RK, et al. Adhesive interactions between alternatively spliced
CD44 isoforms. J Biol Chem 1995; 270: 11567-73. 4. Rafi A, Nagarkatti M, Nagarkatti PS …

Background: CD56 which is considered as a marker of natural killer cells is also expressed
in some cases of acute myelogenous leukemia (AML) and is involved in cell adhesion …

The CD56 antigen is normally expressed on natural-killer cells but has additionally been
shown to be present on a variety of hematologic malignancies, including a subset of acute …

CD56 is a natural killer (NK) cell marker that has been identified in approximately 15–20% of
acute myeloid leukemia (AML) cases, where it has been associated with monocytic …

CD56, a neural cell-adhesion molecule, is expressed in normal NK cells, so the antigen is a
good marker for identifying malignancies in NK cell lineages. 1 CD56 is aberrantly …

We report a patient with lung cancer who developed CD56-positive acute lymphoblastic
leukemia. He was referred to our hospital for thrombocytopenia. Atypical cells were found in …

Blinatumomab, a bispecific T cell engager antibody against CD19/CD3, and inotuzumab
ozogamicin (InO), an anti-CD22 antibody conjugated to calicheamicin, showed significant …

CD56, a neural adhesion molecule, is a marker of natural killer (NK) lymphocytes as well as
a subgroup of CD8+ T cells. Normal lymphocytes with a CD56/CD4 phenotype are scarce …

The neural cell adhesion molecule, CD56, is expressed on acute myelogenous leukemia
(AML) cells in 17–20% of the patients. However, the clinical and biological significance of its …

According to 2022 Who [5], AML myelodysplasia-related (AML-Mr) is defined as a neoplasm
with≥ 20% blasts expressing a myeloid immunophenotype and harboring specific …